EVERSANA, through its Navlin platform, provides strategic pricing and market access consulting services to life science clients, combining in-house expertise with real-time intelligence on pricing, HTA, and regulatory news. The company offers advanced price-management software and launch-sequence simulation tools to support global pharmaceutical launch strategies.
